Spectral AI Reports Q2 2026 Results, Receives FDA Clearance for DeepView Burn System
Spectral AI, Inc. (NASDAQ: MDAI), a Dallas‑based firm that builds artificial‑intelligence diagnostics for wound care...
Read story →Tag: Fda
View all →
Roche Secures FDA Approval for First PTEN-Loss Companion Diagnostic in Prostate Cancer
Roche Diagnostics announced that the U.S. Food and Drug Administration has cleared its VENTANA PTEN (SP218) RxDx Assay, ...
Read story →
CMS Proposes Repeal of Breakthrough Device Pathway in FY 2027 Hospital Payment Rule
On April 14, 2026, the Centers for Medicare & Medicaid Services (CMS) set the stage for a seismic shift in hospital reim...
Read story →